Results

Salarius Pharmaceuticals Inc.

01/13/2022 | Press release | Distributed by Public on 01/13/2022 15:06

Salarius Pharmaceuticals Expands Oncology Pipeline Through Strategic Acquisition of Targeted Protein Degradation Portfolio from DeuteRx, LLC - Form 8-K